IGF-1R

IGF-1R modulator 1 is a selective modulator of the insulin-like growth factor 1 receptor (IGF-1R), exhibiting EC50 values of 0.25 μM for IGF-1R, alongside notable activity against FGFR1, TrkA, and TrkB. This compound is valuable in the study of pathological conditions associated with dysregulated signaling of neurotrophins and trophic factors, including Alzheimer's disease. Its efficacy in modulating IGF-1R offers potential insights into therapeutic approaches for neurodegenerative disorders.

AZ7550 hydrochloride is an inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with an IC50 value of 1.6 μM. This compound demonstrates significant biological activity by disrupting IGF-1R signaling, which plays a critical role in cell proliferation and survival. AZ7550 hydrochloride is primarily used in research applications focused on cancer biology, metabolic diseases, and the molecular mechanisms underlying IGF-1R-related pathways.

AZ7550 Mesylate is a potent inhibitor of the insulin-like growth factor 1 receptor (IGF-1R), exhibiting an inhibitory concentration (IC50) of 1.6 μM. It is utilized in research to study the role of IGF-1R in cellular signaling pathways, cancer proliferation, and resistance mechanisms. This compound serves as a valuable tool for understanding IGF-1R-related diseases and may aid in the development of targeted therapies.

Ceritinib mesylate is a selective ALK tyrosine kinase inhibitor that functions through ATP-competitive mechanisms, exhibiting an IC50 of 200 pM. In addition to its activity against ALK, Ceritinib mesylate also inhibits IGF-1R, InsR, and STK22D, with IC50 values of 8 nM, 7 nM, and 23 nM, respectively. This compound demonstrates significant antitumor potency, making it a valuable tool for research in cancer biology and targeted therapies.